NCT05475626 is a clinical trial of Arthroereisis- in Symptomatic Flexible Flat Feet, sponsored by Mahmoud Ali Hassan Abdelhamid.

Who is sponsoring NCT05475626?

NCT05475626 is sponsored by Mahmoud Ali Hassan Abdelhamid.

What drugs are being tested in NCT05475626?

Interventions in NCT05475626: Arthroereisis-.

What condition does NCT05475626 study?

NCT05475626 studies Symptomatic Flexible Flat Feet.

Is NCT05475626 still recruiting?

NCT05475626 is currently status unknown. Last updated 27 July 2022.

Last reviewed 2022-07-27 · How we verify

NCT05475626

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment Of Symptomatic Pes Planus By Sinus Tarsi Screw Versus Conical Subtalar Screw Arthroereisis

Status unknown Last updated 27 July 2022

What this trial tests

trial testing Arthroereisis- in Symptomatic Flexible Flat Feet in 50 participants. Status unknown.

Timeline

30 August 2022

Primary endpoint
30 May 2023

30 May 2024

Quick facts

Lead sponsor	Mahmoud Ali Hassan Abdelhamid
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	30 August 2022
Primary completion	30 May 2023
Estimated completion	30 May 2024

Drugs / interventions tested

Arthroereisis-

Conditions studied

Symptomatic Flexible Flat Feet — all drugs for Symptomatic Flexible Flat Feet →

Sponsor

Mahmoud Ali Hassan Abdelhamid

Who can join

Adults 7 to 15, any sex, with Symptomatic Flexible Flat Feet. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

compare the outcome of surgical treatment planus by sinus tarsi screw versus conical subtalar screw arthroereisis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05475626 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mahmoud Ali Hassan Abdelhamid
Last refreshed: 27 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05475626.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing